NASDAQ:ARQT | Free Cash Flow | Arcutis Biotherapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$2.24M$0.00$2.24M
2025-12-31$26.19M$0.00$26.19M150.53%
2025-03-31-$30.38M$608,000.00-$30.99M
2024-12-31-$748,000.00$0.00-$748,000.00
2024-03-31-$31.6M$0.00-$31.6M
2023-12-31-$56.24M$6,000.00-$56.25M
2023-03-31-$80.34M$82,000.00-$80.43M
2022-12-31-$71.07M$123,000.00-$71.19M
2022-03-31-$56.98M$124,000.00-$57.1M
2021-12-31-$51.71M$261,000.00-$51.97M
2021-03-31-$46.2M$554,000.00-$46.76M
2020-12-31-$32.57M$153,000.00-$32.72M
2020-03-31-$21.01M$41,000.00-$21.05M
2019-12-31-$16.8M$66,000.00-$16.86M
2019-03-31-$7.07M$183,000.00-$7.26M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$5.63M$686,000.00-$6.31M
2024-12-31-$112.16M$143,000.00-$112.3M
2023-12-31-$247.06M$428,000.00-$247.49M
2022-12-31-$257.72M$333,000.00-$258.05M
2021-12-31-$174.63M$995,000.00-$175.62M
2020-12-31-$113.03M$321,000.00-$113.35M
2019-12-31-$42.84M$295,000.00-$43.13M
2018-12-31-$14.09M$0.00-$14.09M